Amy Goundry: Introducing Blood and Plasma
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”Introducing Blood and Plasma
We’re pleased to share that Plasmatology has entered a new chapter as Blood and Plasma, reflecting an expanded vision across the full spectrum of blood and plasma science, from fundamental biology to translational and clinical research.
To mark this, we invite submissions to two new Special Collections that highlight the journal’s broadened aims and scope:
- Therapeutic Innovations in Plasma Science: Immunomodulation and Clinical Impact
- Mechanistic Insights into Immune Regulation by Blood and Plasma Components
Submission deadline: July 30, 2026
A discounted APC of USD 1,500 applies to articles submitted during this period.
Blood and Plasma is a gold open-access journal committed to rigorous peer review, ethical publishing, and global accessibility.
The journal is now also available on ResearchGate, expanding its reach within the research community.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters